Dr Smith Pieter in Berea, KwaZulu-Natal
-
CMS proposes faster prior-authorization rules for drugs
CMS has proposed new electronic prior-authorization rules for drugs that could shorten some approval waits, but the change is not final. The plan would still need public comments, a final rule, and plan-by-plan implementation before patients see any effect.
-
Type 1 vs. Type 2 Diabetes: Key Differences Everyone Should Understand
This article clearly explains how Type 1 and Type 2 diabetes differ in cause, onset, and care so patients and caregivers can make informed decisions. Type 1 is an autoimmune condition that rapidly destroys insulin-producing cells, often starting in childhood or young adulthood and requiring lifelong insulin. Type 2 develops more gradually from insulin resistance, is more common in adults, and is often managed first with lifestyle changes and oral medications, though insulin may be needed. You’ll learn key risk factors, typical warning signs, how diagnosis is made, and how to prevent complications through glucose monitoring, checkups, and healthy habits. The goal is to help you recognize symptoms early, understand treatment options, and partner confidently with your healthcare team.
-
What the CDC’s Cruise Ship Hantavirus Alert Means for Travelers and Families
The CDC says the public risk from the cruise ship hantavirus outbreak is very low, but a small group of exposed travelers is being monitored for up to 42 days. Here’s what Andes virus is, how it spreads, which symptoms matter, and what exposed passengers and families should do next.
-
About Weence | Health | News | Resources
About Weence: Clear, Evidence-Based Health Reporting for Everyday Readers
Weence publishes plain-language public health and medical reporting to help readers understand new studies, outbreaks, healthcare policy changes, and preventive guidance—without hype or confusion.